Drug Profile
Research programme: neurodegenerative disorder therapeutics - Neuropore Therapies
Alternative Names: NPT 1220 312; Toll-like receptor modulators - Neuropore therapiesLatest Information Update: 28 Mar 2024
Price :
$50
*
At a glance
- Originator Neuropore Therapies
- Class Neuroprotectants; Small molecules
- Mechanism of Action Autophagy modulators; Toll like receptor 2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Amyotrophic lateral sclerosis; Neurodegenerative disorders
Most Recent Events
- 28 Mar 2024 No recent reports of development identified for preclinical development in Amyotrophic-lateral-sclerosis in USA (PO)
- 28 Oct 2020 No recent reports of development identified for research development in Neurodegenerative-disorders in USA (PO)
- 29 Sep 2020 Global Cancer Technology in-licenses small molecule autophagy modulators from Neuropore Therapies